| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 01/02/2002 | EP1135151A4 Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors |
| 01/02/2002 | CN1329620A Analogues of GLP-1 |
| 01/02/2002 | CN1329616A Acylated benzylmal tosides as inhibitors of smooth muscle cell proliferaton |
| 01/02/2002 | CN1329614A Fused pyridazine derivatives, process for preparation of same and uses thereof |
| 01/02/2002 | CN1329601A New benzimidazolone-benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents |
| 01/02/2002 | CN1329599A 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators |
| 01/02/2002 | CN1329594A Ureidopiperidine derivatives as selective human NK3 receptor antagonists |
| 01/02/2002 | CN1329506A Formulation with an improved therapeutic range, cntainng nucleotide synthesis inhibitors |
| 01/02/2002 | CN1329505A Composition and method for treating allergic diseases |
| 01/02/2002 | CN1329501A Therapeutic agent for suppression of snoring noises |
| 01/02/2002 | CN1329496A Methods and cmpositions for prevention of tolerance to medications |
| 01/02/2002 | CN1329491A Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants |
| 01/02/2002 | CN1329490A Composition and method for treating allergic diseases |
| 01/02/2002 | CN1328847A Chinese medicine preparation for curing pneumoconiosis |
| 01/02/2002 | CN1328840A Medicated bag for curing tussis |
| 01/02/2002 | CN1077103C Chiral methyl phenyl oxazolidinones |
| 01/01/2002 | US6335451 Five-membered heterocycles having biphenylsulfonyl substitution, with sulfonylcyanamide side chain, compositions containing them, and methods of using them |
| 01/01/2002 | US6335448 Method for the synthesis of quinoline derivatives |
| 01/01/2002 | US6335433 nrdD |
| 01/01/2002 | US6335352 Administering heterocyclic cyanoguanidine derivatives as chemokine inhibitors |
| 01/01/2002 | US6335342 Azaindole derivatives, process for their preparation, and their use as antitumor agents |
| 01/01/2002 | US6335334 Hypertensive agents, anticoagulants; cardiovascular and sexual disorders, angina pectoris, and atherosclerosis |
| 01/01/2002 | US6335331 Antihistamines, antiallergens, brochodilator agents and antispasmodic agents |
| 01/01/2002 | US6335329 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 01/01/2002 | US6335324 Treating asthma or allergic rhinitis |
| 01/01/2002 | US6335320 Method of treating fibrotic conditions |
| 01/01/2002 | US6335182 Recombinant Haemophilus influenzae adhesin proteins |
| 01/01/2002 | CA2215333C Heterocyclic substituted piperazinone derivatives as tachykinin receptor antagonists |
| 01/01/2002 | CA2093789C Bi-aromatic compounds and their use in human and veterinary medicine and in cosmetic preparations |
| 01/01/2002 | CA2056799C 1,4-dihydropyridine derivatives and methods of producing the same |
| 01/01/2002 | CA2023858C (+)-isomers of endoetheno/endoethano-epoxymorphinan derivatives as antitussive agents |
| 12/29/2001 | CA2351904A1 Target |
| 12/27/2001 | WO2001098508A2 Transgenic mice containing targeted gene disruptions |
| 12/27/2001 | WO2001098490A1 A g-protein coupled receptor |
| 12/27/2001 | WO2001098473A2 Method for isolating and purifying a protein and resulting protein |
| 12/27/2001 | WO2001098364A2 Peptides, compositions and methods for the treatment of burkholderia cepacia |
| 12/27/2001 | WO2001098362A2 Chemically-modified antimicrobial peptides, compositions and methods of production and use |
| 12/27/2001 | WO2001098357A2 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations |
| 12/27/2001 | WO2001098353A2 Secreted proteins |
| 12/27/2001 | WO2001098334A2 Streptococcus antigens |
| 12/27/2001 | WO2001098332A2 Secreted redox proteins |
| 12/27/2001 | WO2001098323A2 G-protein coupled receptors |
| 12/27/2001 | WO2001098301A1 Pyrazolopyridine compounds and use thereof as drugs |
| 12/27/2001 | WO2001098299A1 Azaindole derivatives, process for their preparation, and their use as antitumor agents |
| 12/27/2001 | WO2001098291A2 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders |
| 12/27/2001 | WO2001098289A1 Novel non-psychotropic cannabinoids |
| 12/27/2001 | WO2001098286A1 Nitrosated and nitrosylated taxanes, compositions and methods of use |
| 12/27/2001 | WO2001098273A1 Novel compounds |
| 12/27/2001 | WO2001098272A1 Novel compounds |
| 12/27/2001 | WO2001098270A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/27/2001 | WO2001098269A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/27/2001 | WO2001098268A2 Piperidine amides as modulators of chemokine receptor activity |
| 12/27/2001 | WO2001098245A2 Triphenyl compounds as interleukin-4 antagonists |
| 12/27/2001 | WO2001097837A1 Solubilised protein vaccines |
| 12/27/2001 | WO2001097836A1 Compositions and methods for treatment of candidiasis |
| 12/27/2001 | WO2001097821A1 Immunotherapy or treating bacterial or viral infection at mucosal surfaces with probiotics, and compositions therefor. |
| 12/27/2001 | WO2001097813A2 Highly concentrated stable meloxicam solutions |
| 12/27/2001 | WO2001097786A2 Benzothiazole derivatives |
| 12/27/2001 | WO2001097753A2 Novel methods using pyridine derivatives |
| 12/27/2001 | WO2001097627A1 Throat care agents |
| 12/27/2001 | WO2001078894A9 Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease |
| 12/27/2001 | WO2001064659A3 Indane derivatives and their use as cell adhesion inhibitors |
| 12/27/2001 | WO2001060349B1 Pharmacological agent comprising picolinic acid, fusaric acid and derivatives thereof. |
| 12/27/2001 | WO2001057042A3 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy |
| 12/27/2001 | WO2001049711A3 Nucleic acids encoding (poly)peptides having chips activity |
| 12/27/2001 | WO2001046256A3 Vesicle trafficking proteins |
| 12/27/2001 | WO2001023390A3 Azepinoindole derivatives, the production and use thereof |
| 12/27/2001 | WO2000064485A3 Specifically targeted catalytic antagonists and uses thereof |
| 12/27/2001 | US20010056183 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 12/27/2001 | US20010056122 Therapies for treating pulmonary diseases |
| 12/27/2001 | US20010056107 Cyano and carboxy derivatives of substituted styrenes are inhibitors of tumor necrosis factor alpha , nuclear factor kappa B, and phosphodiesterase and can be used to treat cachexia, endotoxic shock, inflammatory conditions etc. |
| 12/27/2001 | US20010056100 Carboxylic acid or tetrazole derivatives containing carbamate groups are useful for treating the conditions associated with the urinary tract, pain, inflammation, respiratory states, edema formation of hypotensive vascular diseases |
| 12/27/2001 | US20010056076 Treatment of acute lung injury and fibrosis with antagonists of alphavbeta6 |
| 12/27/2001 | CA2414010A1 Secreted redox proteins |
| 12/27/2001 | CA2413878A1 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders |
| 12/27/2001 | CA2413866A1 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations |
| 12/27/2001 | CA2413454A1 A g-protein coupled receptor |
| 12/27/2001 | CA2413450A1 Streptococcus antigens |
| 12/27/2001 | CA2413421A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/27/2001 | CA2413418A1 Piperidine amides as modulators of chemokine receptor activity |
| 12/27/2001 | CA2413274A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/27/2001 | CA2412484A1 G-protein coupled receptors |
| 12/27/2001 | CA2412011A1 Chemically-modified antimicrobial peptides, compositions and methods of production and use |
| 12/27/2001 | CA2411978A1 Transgenic mice containing targeted gene disruptions |
| 12/27/2001 | CA2411912A1 Compositions and methods for treatment of candidiasis |
| 12/27/2001 | CA2411865A1 Azaindole derivatives, process for their preparation, and their use as antitumor agents |
| 12/27/2001 | CA2411857A1 Peptides, compositions and methods for the treatment of burkholderia cepacia |
| 12/27/2001 | CA2411585A1 Novel non-psychotropic cannabinoids |
| 12/27/2001 | CA2411255A1 Novel compounds |
| 12/27/2001 | CA2410632A1 Nitrosated and nitrosylated taxanes, compositions and methods of use |
| 12/27/2001 | CA2409778A1 Secreted proteins |
| 12/26/2001 | CN1328555A Novel salts of pyridopyrazine compound and crystals thereof |
| 12/26/2001 | CN1328548A Benzamide derivatives as thrombin inhibitors |
| 12/26/2001 | CN1328547A 2,3-Disubstituted pyridine derivatives, process for preparation thereof, drug compositions containing the same and intermediates for preparation |
| 12/26/2001 | CN1328545A Hydrazine derivatives |
| 12/26/2001 | CN1328538A 2,4-pentadienoic acid derivatives having selective activity for retinoid X(RXR) receptors |
| 12/26/2001 | CN1328473A Medicinal aerosol formulation |
| 12/26/2001 | CN1328466A Use of antifungal agents for treating scleroses |
| 12/26/2001 | CN1328454A Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
| 12/26/2001 | CN1328447A Process for producing particles with converted amorphous and/or meta-stable crystalline region into crystalline state |